Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -7.94 | 15.15 |
| PEG Ratio (TTM) | 0.00 | -0.59 |
| P/S Ratio (TTM) | 1.01 | 0.85 |
| P/B Ratio (TTM) | 0.70 | 1.32 |
| P/FCF Ratio (TTM) | -8.93 | 5.85 |
| Price to 5YR AVG Earnings Ratio | N/A | 7.77 |
| Price to 5YR AVG FCF Ratio | N/A | 8.42 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -5.61% | 5.87% |
| ROE (TTM) | -8.78% | 8.86% |
| Net Profit Margin (TTM) | -13.06% | 5.84% |
| ROIC 5YR AVG | N/A | 20.82% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -722.23% | 13.85% | N/A |
| Revenue | -15.50% | 36.02% | N/A |
| Net Income | -744.56% | 13.42% | N/A |
| Cash Flow | 7.31% | 38.18% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.44 | 2.48 |
| Quick Ratio (TTM) | 1.16 | 1.42 |
| D/E Ratio (TTM) | 0.50 | 0.36 |
| Interest Coverage (TTM) | N/A | 29.50 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 1.60 | 3.69 |
| LTL to 5YR AVG FCF | N/A | 2.70 |
| Shares Outstanding Growth 5YR AVG | N/A | -2.94% |